Neuropathological Correlates of Dementia in Over-80-Year-Old Brain Donors from the Population-Based Cambridge City over-75s Cohort (CC75C) Study
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Key neuropathological changes associated with late-onset dementia are not fully understood. Population-based longitudinal studies offer an opportunity to step back and examine which pathological indices best link to clinical state. CC75C is a longitudinal study of the population aged 75 and over at baseline in Cambridge, UK. We report on the first 213 participants coming to autopsy with sufficient information for an end of life dementia diagnosis. Clinical diagnosis was ascertained by examining retrospective informant interviews, survey responses, and death certificates according to DSM-IV criteria. The neuropathological protocol was based on the Consortium to Establish a Registry of Alzheimer's Disease (CERAD). Clinical dementia was present in 113 participants (53%): 67% with Alzheimer's disease, 4% vascular dementia, 22% mixed dementia, and 1% dementia with Lewy bodies. As Alzheimer-type pathology was common, the mutually blinded clinical and neuropathological diagnoses were not strongly related. Multivariable analysis identified associations between dementia during life and entorhinal cortex neuritic plaques, hippocampal diffuse plaques, neocortical neurofibrillary tangles, white matter pallor, Lewy bodies, and hippocampal atrophy. These results were consistent in those with clinical Alzheimer's disease. Vascular pathologies, especially microinfarcts, were more common in those with clinical diagnoses including vascular dementia. Alzheimer-type and cerebrovascular pathology are both common in the very old. A greater burden of these pathologies, Lewy bodies, and hippocampal atrophy, are associated with a higher risk of, but do not define, clinical dementia in old age.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“both lead to cognitive decline and dementia”
From Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration (2013) · cites this paper as [5]
In the citing paper
“AD has generally been attributed to be the neuropathological cause in between 65% and 75% of dementia cases (42, 43).”
From Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010 (2012) · cites this paper as [43]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282 · cited 4×
“Subsequently participants whose MMSE scores suggested normal to high cognitive function were also recruited to the brain donation programme to ensure the sample included the full population spectrum.”
InfluentialMcKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Global prevalence of dementia: a Delphi consensus study
Ferri, C. P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K., Hasegawa, K., Hendrie, H., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,332 · cited 1×
“The “oldest-old” are the fastest-growing population group in developed countries and also have the greatest incidence of dementia [1].”
Self-citationDiagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Self-citationMirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Staging of alzheimer's disease-related neurofibrillary changes
Braak, H., & Braak, E. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00021-6 · Cited by 2,357 · cited 1×
“Ratings for tau reactive plaques and tangles were estimated according to Braak Staging [21] and ratings for diffuse amyloid-β-reactive plaques were estimated according to the age dependent CERAD protocol [20] for all areas.”
Roth, M., Tym, E., Mountjoy, C. Q., Huppert, F. A., Hendrie, H., Verma, S., & Goddard, R. (1986) · British Journal of Psychiatry · doi:10.1192/bjp.149.6.698 · Cited by 2,090 · cited 5×
“Besides the in-depth CAMDEX assessments made on many donors, retrospective interviews were sought with relatives after a donor’s death to obtain further information on the period between the participant’s last interview and death.”
MethodInfluentialSelf-citationMixed brain pathologies account for most dementia cases in community-dwelling older persons
Schneider, J. A., Arvanitakis, Z., Bang, W., & Bennett, D. A. (2007) · Neurology · doi:10.1212/01.wnl.0000271090.28148.24 · Cited by 1,992 · cited 2×
“Furthermore, few of these studies have been able to compare neuropathology across clinically diagnosed dementia sub-types [4,7,9].”
Age, Neuropathology, and Dementia
Savva, G. M., Wharton, S. B., Ince, P. G., Forster, G., Matthews, F. E., & Brayne, C. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806142 · Cited by 900
Self-citationCerebral White Matter Lesions and the Risk of Dementia
Prins, N. D., van Dijk, E. J., den Heijer, T., Vermeer, S. E., Koudstaal, P. J., Oudkerk, M., Hofman, A., & Breteler, M. M. B. (2004) · Archives of Neurology · doi:10.1001/archneur.61.10.1531 · Cited by 488 · cited 1×
“White matter lesions have been reported in relation to dementia previously [9,27] and cognitive decline [28].”
Cited by
Items 101–192 of 192
Insights into the pathological basis of dementia from population‐based neuropathology studies
Wharton, S. B., Simpson, J. E., Ince, P. G., Richardson, C. D., Merrick, R. L., Matthews, F. E., Brayne, C., & CFAS (2023) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12923 · Cited by 28
Self-citationPrajjwal, P., Marsool, M. D. M., Inban, P., Sharma, B., Asharaf, S., Aleti, S., Gadam, S., Sakini, A. S. A., & Hadi, D. D. (2023) · Disease-a-Month · doi:10.1016/j.disamonth.2023.101557 · Cited by 32
Increasing incidence of dementia in the oldest old: evidence and implications
James, B. D., & Schneider, J. A. (2010) · Alzheimer s Research & Therapy · doi:10.1186/alzrt32 · Cited by 33
Vascular dementia: World Stroke Organization fact sheet 2026
Cai, Y., Mok, V., & Markus, H. S. (2026) · International Journal of Stroke · doi:10.1177/17474930251404243 · Cited by 31
de Rotte, A. A. J., Koning, W., den Hartog, A. G., Bovens, S. M., Zwanenburg, J. J. M., Klomp, D. W. J., Pasterkamp, G., Moll, F. L., Luijten, P. R., de Borst, G. J., et al. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.141 · Cited by 21
Neuropathological Profile of Mild Cognitive Impairment From a Population Perspective
Stephan, B. C. M., Matthews, F. E., Hunter, S., Savva, G. M., Bond, J., McKeith, I. G., Ince, P. G., & Brayne, C. (2011) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31822fc24d · Cited by 23
“It is not always possible to separate demented and nondemented individuals pathologically such that postmortem brains of individuals who do not fulfill criteria for dementia at death can demonstrate significant pathology and individuals with dementia can show little or no pathology.(28,37,38) Given the difficulty in u…”
BackgroundSelf-citationAntihypertensive medications ameliorate Alzheimer's disease pathology by slowing its propagation
Affleck, A. J., Sachdev, P. S., Stevens, J., & Halliday, G. M. (2020) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12060 · Cited by 24
Preventing Vascular Effects on Brain Injury and Cognition Late in Life: Knowns and Unknowns
Carmichael, O. T. (2014) · Neuropsychology Review · doi:10.1007/s11065-014-9264-7 · Cited by 20
“These studies suggest that among individuals who die clinically demented, a common autopsy finding is an admixture of cerebrovascular, Alzheimer, and Lewy body pathologies (Brayne et al. 2009; Schneider et al. 2007a; White et al. 2005a).”
Clinical-pathologic correlations in vascular cognitive impairment and dementia
Flanagan, M. E., Larson, E. B., Latimer, C. S., Cholerton, B., Crane, P. K., Montine, K. S., White, L. R., Keene, C. D., & Montine, T. J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.08.019 · Cited by 17
Epidemiology of Cognitive Aging in the Oldest Old
Giulioli, C., & Amieva, H. (2016) · Revista de investigaci�n Cl�nica · doi:10.1016/s0034-8376(25)00205-0 · Cited by 20
Tripathy, A., Shade, A., Erskine, B., Bailey, K., Grande, A. J., deLong, J. J., Perry, G. L., & Castellani, R. J. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181039 · Cited by 17
“…with the neuropathological literature, in which common psychiatric conditions are not defined by proteinopathy on post mortem examination, and in which pro-teinopathy does not predict severity of cognitive dysfunction or other neurological signs with any degree of precision [22, 24, 38–41].”
Paradigm Shift: Multiple Potential Pathways to Neurodegenerative Dementia
Perna, A., Montine, K. S., White, L. R., Montine, T. J., & Cholerton, B. (2023) · Neurotherapeutics · doi:10.1007/s13311-023-01441-w · Cited by 16
“However, neuropathologic investigations in established cohorts [6, 12, 13] have unveiled the frequent co-occurrence of multiple neurodegenerative processes, raising important questions about the ultimate effectiveness of single-pathway approaches in patients likely to harbor co-morbid disease…”
BackgroundAβ and the dementia syndrome: Simple versus complex perspectives
Hunter, S., Smailagic, N., & Brayne, C. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.13025 · Cited by 16
“(1) The amyloid cascade hypothesis,(20-22) Figure 1A, is a hierarchical model that synthesises the genetic, neuropathological and clinical evidence to invest Aβ, whether by increased total Aβ levels, increased ratio of Aβ(1-42)/Aβ(1-40) 21,22 or oligomers,(28-30) with a toxic and causal role in AD initiation and progr…”
BackgroundSelf-citationKatsumata, Y., Wu, X., Aung, K. Z., Fardo, D. W., Woodworth, D. C., Sajjadi, S. A., Tomé, S. O., Thal, D. R., Troncoso, J. C., Chang, K., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02821-y · Cited by 15
Hunter, S., Hokkanen, S. R. K., Keage, H. A. D., Fleming, J., Minett, T., Polvikoski, T. M., Allinson, K. S. J., & Brayne, C. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191093 · Cited by 15
Self-citationMiceli, V., Russelli, G., Iannolo, G., Gallo, A., Re, V. L., Agnese, V., Sparacia, G., Conaldi, P. G., & Bulati, M. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111332 · Cited by 15
Muzambi, R., Bhaskaran, K., Rentsch, C. T., Smeeth, L. L., Brayne, C., Garfield, V., Williams, D. M., Chaturvedi, N., & Warren‐Gash, C. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02145-z · Cited by 16
“Before the clinical expression of dementia, cognitive and neuropathological changes associated with dementia progression can be observed but it is unclear whether infections are relevant during this process [8, 9].”
BackgroundSelf-citationAntemortem Prediction of Braak Stage
Carlson, J. O. E., Gatz, M., Pedersen, N. L., Graff, C., Nennesmo, I., Lindström, A.-K., & Gerritsen, L. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000251 · Cited by 16
The unique neuropathological vulnerability of the human brain to aging
Ferrer, I. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101916 · Cited by 18
“…with other age-related proteinopathies which have and additive effect on cognitive and neuropsychiatric impairment in old age (Higashi et al., 2007; Brayne et al., 2009; Kovacs et al., 2013; Kovacs et al., 2015; Elobeid et al., 2016; Spires-Jones et al., 2017; Robinson et al., 2018a, 2018b;…”
BackgroundSachdeva, D., & Burns, A. S. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00156.x · Cited by 14
Differentiating between dementia, delirium and depression in older people
Dening, K. H. (2019) · Nursing Standard · doi:10.7748/ns.2019.e11361 · Cited by 14
Chronic traumatic encephalopathy: A paradigm in search of evidence?
Castellani, R. J. (2015) · Laboratory Investigation · doi:10.1038/labinvest.2015.54 · Cited by 14
Chertkow, H. M. (2018) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2018.27 · Cited by 17
“The majority of older individuals with dementia have mixed pathology in their brain (11, 12, 20, 21).”
Gertz, H., & Kurz, A. (2011) · Der Nervenarzt · doi:10.1007/s00115-010-3213-3 · Cited by 16
Tanskanen, M., Kalaria, R. N., Notkola, I.-L., Mäkelä, M. J., Polvikoski, T. M., Myllykangas, L., Sulkava, R. O., Kalimo, H., Paetau, A. E., Scheltens, P., et al. (2013) · Current Alzheimer Research · doi:10.2174/15672050113106660177 · Cited by 15
Exploring the combined effects of sleep apnea and APOE-e4 on biomarkers of Alzheimer’s disease
Turner, A. D., Locklear, C. E., Oruru, D., Briggs, A., Bubu, O. M., & Seixas, A. A. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1017521 · Cited by 12
Cognitive Outcomes of Cardiovascular Surgical Procedures in the Old: An Important but Neglected Area
Keage, H. A. D., Smith, A. E., Loetscher, T., & Psaltis, P. J. (2016) · Heart Lung and Circulation · doi:10.1016/j.hlc.2016.09.002 · Cited by 12
Di, J., Nelson, R. S., Jicha, G. A., Moga, D. C., Barber, J. M., Cykowski, M. D., Fardo, D. W., Abner, E. L., & Nelson, P. T. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230425 · Cited by 8
“Moreover, pathology subtypes in the same brain are the rule and not the exception in persons dying beyond age 85 years [12, 18–20].”
Burton, E. J., Mukaetova-Ladinska, E. B., Perry, R. H., Jaros, E., Barber, R., & O'Brien, J. T. (2012) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3774 · Cited by 10
“Tau pathology is seen in varying degrees in the brains of most individuals (Brayne et al., 2009) and there is evidence of an overlap in the distribution and amount of Alzheimer type pathology in patients with and without dementia, with the amount of Alzheimer pathology increasing with age at death…”
BackgroundSelf-citationBodryzlova, Y., Mehrabi, F., Bosson, A., Maïano, C., André, C., Bélanger, E., & Moullec, G. (2023) · Journal of Aging & Social Policy · doi:10.1080/08959420.2023.2245672 · Cited by 9
The APP Proteolytic System and Its Interactions with Dynamic Networks in Alzheimer’s Disease
Hunter, S., Martin, S., & Brayne, C. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2627-5_3 · Cited by 8
Self-citationBrain Imaging Abnormalities in Mixed Alzheimer’s and Subcortical Vascular Dementia
Lee, H., Wiggermann, V., Rauscher, A., Kames, C., Beg, M. F., Popuri, K., Tam, R. C., Lam, K., Jacova, C., Shahinfard, E., et al. (2022) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2022.65 · Cited by 8
Wu, K.-Y., Lin, K., Chen, C., Liu, C.-Y., Wu, Y.-M., Yen, T., & Hsiao, I. (2023) · Biomedical Journal · doi:10.1016/j.bj.2023.03.002 · Cited by 8
Mavrogiorgou, P., Gertz, H., Ferszt, R., Wolf, R. J., Bär, K., & Juckel, G. (2011) · PubMed · Cited by 10
The Epidemiological Neuropathology of Dementia and the Implications for Drug Development
Stephan, B. C. M., Wharton, S. B., Simpson, J. E., Matthews, F. E., Ince, P. G., & Brayne, C. (2012) · Neurodegenerative Disease Management · doi:10.2217/nmt.12.51 · Cited by 7
Self-citationDémences : où sont les corps de Lewy ?
Lebouvier, T., Delrieu, J., Evain, S., Pallardy, A., Sauvaget, A., Letournel, F., Chevrier, R., Lepetit, M., Vercelletto, M., Boutoleau‐Bretonnière, C., et al. (2013) · Revue Neurologique · doi:10.1016/j.neurol.2013.05.004 · Cited by 7
Cognitive resilience in ageing: determinants and interventions
Powell, A., Chan, K., Shepherd, C. E., & Brodaty, H. (2026) · The Lancet Neurology · doi:10.1016/s1474-4422(26)00027-x · Cited by 13
Hunter, S., & Brayne, C. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.015 · Cited by 7
Self-citationDementia Research: Populations, Progress, Problems, and Predictions
Hunter, S., Smailagic, N., & Brayne, C. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179927 · Cited by 7
“…drives disease Complex relationships between dementia status and amyloid neuropathologies do not fully support the ACH in the population [13, 20, 24, 30, 31, 41, 42] PSH [43–45] Altered PS function drives disease Not fully tested in the population - mutations may affect A (cid:2) PP…”
InfluentialSelf-citationBowirrat, A., Yassin, M., Abir, M., Bisharat, B., & Armaly, Z. (2012) · InTech eBooks · doi:10.5772/48558 · Cited by 8
“These compounds may protect the cells from beta A(1-42) insult through antioxidant pathways.”
BackgroundResultHunter, S., Walsh, S., & Brayne, C. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03156-0 · Cited by 8
“For the majority of those with dementia in the older population, diagnoses of AD based on clinical features correspond only moderately with the neuro-pathology seen at death in population-based clinicopathological studies [28, 35, 36, 57].”
Self-citationCurrent Pathogenetic Concepts of Vascular Cognitive Impairment
Ka, J. (2016) · Journal of Neurology Neurological Science and Disorders · doi:10.17352/jnnsd.000009 · Cited by 5
“The prevalence studies must be interpreted cautiously since aged subjects with and without dementia show a high frequency of mixed pathologies [18-22].”
BackgroundClosing the gap in dementia research by community-based cohort studies in the Chinese population
Zhou, X., Xiao, Z., Wu, W., Chen, Y., Yuan, C., Leng, Y., Yao, Y., Zhao, Q., Hofman, A., Brunner, E. J., et al. (2025) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2025.101465 · Cited by 7
“…studies were mostly in developed countries, including the Hisayama study in Japan, 167 the Cognitive Function and Ageing Study 168 and the Cambridge City over − 75s Cohort Study 169 in the UK, the Honolulu-Asia Aging Study, 170 and the Cache County Study on Memory and Aging 171 in the US.”
Plaques and tangles: Birthmarks of the aging soul
Perry, G. L., & Castellani, R. J. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.028 · Cited by 4
“In contrast, Ab and tau correlate weakly, if at all, with cognitive decrement in those over 85 years of age [10].”
BackgroundVascular Dementia and Cognitive Impairment
Seshadri, S. S., Economos, A., & Wright, C. B. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-29544-4.00017-7 · Cited by 4
Epidemiology of Mental Disorders (Including Cross-Cultural Comparisons)
Kua, E. H., & Mahendran, R. (2017) · Mental health and illness worldwide · doi:10.1007/978-981-10-2414-6_5 · Cited by 6
Higginbotham, L. A., Carter, K., Dammer, E. B., Haque, R. U., Johnson, E. C. B., Duong, D. M., Yin, L., Jager, P. L. D., Bennett, D. A., Lah, J. J., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.22.501017 · Cited by 4
“Several studies have confirmed that those with AD dementia commonly harbor brain pathologies beyond Aβ plaques and NFTs, including cerebrovascular disease, neocortical Lewy body inclusions, and TAR DNA-binding protein 43 (TDP-43) aggregates [8-12].”
BackgroundVascular Dementia and Cognitive Impairment
Seshadri, S. S., Caunca, M. R., & Rundek, T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-69424-7.00018-1 · Cited by 3
Drożak, P., Skrobas, U., & Drożak, M. (2022) · Journal of Education Health and Sport · doi:10.12775/jehs.2022.12.09.097 · Cited by 5
A life course approach to neurodegeneration
James, S., Schott, J. M., & Ben‐Shlomo, Y. (2025) · Oxford University Press eBooks · doi:10.1093/oso/9780198895961.003.0011 · Cited by 2
Saiz-Vázquez, O., Landa, S. U., & Puente-Martínez, A. (2025) · Kidney & Blood Pressure Research · doi:10.1159/000546395 · Cited by 4
Jung, Y. H., Kim, J. P., Kim, H. J., Jang, H., Han, H. J., Koh, Y. H., Na, D. L., Suh, Y., Huh, G. Y., Won, J., et al. (2025) · Journal of Clinical Neurology · doi:10.3988/jcn.2024.0517 · Cited by 2
Vascular dementia: why pathology is still important
Neal, J. (2011) · Reviews in Clinical Gerontology · doi:10.1017/s0959259811000207 · Cited by 2
Neuropathological Correlates of Falling in the CC75C Population-Based Sample of the Older Old
Richardson, K., Hunter, S., Dening, T., Xuereb, J. H., Matthews, F. E., Brayne, C., & Fleming, J. (2012) · Current Alzheimer Research · doi:10.2174/156720512801322636 · Cited by 3
“Dementia status from clinical diagnosis has been described in detail elsewhere [42].”
Self-citationCapuano, A. W., Wilson, R. S., Schneider, J. A., Leurgans, S. E., & Bennett, D. A. (2018) · Biostatistics & Epidemiology · doi:10.1080/24709360.2018.1500089 · Cited by 2
Amyloid in the ageing brain: New frameworks and perspectives
Hunter, S., & Brayne, C. (2021) · Aging Brain · doi:10.1016/j.nbas.2021.100008 · Cited by 2
Self-citationMu, R., Qin, X., Zheng, W., Yang, P., Huang, B., Li, X., Liu, F., Deng, K., & Zhu, X. (2024) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-23-1464 · Cited by 3
The Brain Aging National Cohort-PUMC: study design and baseline characteristics
Han, F., Qiu, W., Zhou, L., Ni, J., Yao, M., Liu, Y., Hou, B., Cui, R., Feng, F., Li, F., et al. (2023) · Human Brain · doi:10.37819/hb.2.333 · Cited by 2
Chun, M. Y., Park, Y. H., Kim, H. J., Na, D. L., Kim, J. P., Seo, S. W., & Jang, H. (2025) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000005793 · Cited by 1
Farfel, J. M., Capuano, A. W., Nag, S., Sampaio, M. C. M., Gibbons, J., Wilson, R. S., & Bennett, D. A. (2025) · Neuroepidemiology · doi:10.1159/000547564 · Cited by 1
Brundel, M., Kappelle, J. L. J., & Biessels, G. J. (2012) · Neuropraxis · doi:10.1007/s12474-012-0031-3 · Cited by 2
“Arvanitakis et al., 2011 controles (233) 25,3 microscopisch x Brayne et al., 2009 controles (100) 43 x x”
BackgroundInfluentialEpidemiology of Mental Disorders (Including Cross-Cultural Comparisons)
Kua, E. H., & Mahendran, R. (2016) · Mental health and illness worldwide · doi:10.1007/978-981-10-0370-7_5-1 · Cited by 1
Hyperbaric oxygen therapy—a new hope for Alzheimer’s patients: a case report and literature review
Mukaetova-Ladinska, E. B., Steptoe, J., Critchfield, M., Yoon, H.-J., Sharif, M., & Arshad, Q. (2023) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2023.00062 · Cited by 1
Self-citationWindon, C., & Elahi, F. M. (2024) · Springer eBooks · doi:10.1007/978-3-031-49963-0_30 · Cited by 1
Avan, A., Amiri, A., Mokhber, N., Erfanian, M., Cipriano, L. E., Stranges, S., Shojaeianbabaei, G., Abootalebi, S., & Azarpazhooh, M. R. (2021) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2021.05.044 · Cited by 1
Brain pathological changes from population-based studies
Cao, Y., Huang, M., Shu, M.-J., & Zhu, Y. (2022) · Human Brain · doi:10.37819/hb.001.001.0205 · Cited by 1
Associação entre diabetes mellitus e demência: estudo neuropatológico
Matioli, M. N. P. D. S. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2016.tde-18112016-111336 · Cited by 3
Schieb, H. (2011) · DuEPublico (University of Duisburg-Essen)
Tau Protein, Ischemic Injury and Vascular Dementia
Mukaetova-Ladinska, E. B., Li, M., & Kalaria, R. N. (2015) · Future Neurology · doi:10.2217/fnl.15.46
Self-citationPredictors of Dementia and Memory Decline: Lifecourse Socioeconomic Status and Diabetes
Marden, J. R. (2016) · Digital Access to Scholarship at Harvard (DASH) (Harvard University) · Cited by 1
Cognitive disorders of the very old
Valcour, V., & Masaki, K. (2016) · Cambridge University Press eBooks · doi:10.1017/9781139924771.026
Predicting Cognitive Decline in Patients with TIA and Minor Stroke
Munir, M. A. (2016) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/27401
Studying Vascular Morphologies in the Aged Human Brain Using Large Autopsy Datasets
Ighodaro, E. T. (2018) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2018.049
“More specifically, the cutoff of 80 years was chosen because it has been used before to help highlight neurodegenerative disease and/or neuropathologic features that differ – often quite dramatically – among the “oldest-old” [53, 84-86, 101, 102].”
MethodAging, cognitive ability and the risk of dementia in the Helsinki Birth Cohort Study
Rantalainen, V. (2019) · Helda - University of Helsinki Institutional Repository · Cited by 1
Diffusion Tensor Imaging and Cognition of Transient Ischemic Attack Patients and Healthy Controls
Tariq, S. (2018) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/31920
Family of protein fragments promises fresh view of Alzheimer's disease
Schubert, C. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1905886116
Neuropathology of Alzheimer’s Disease and Vascular Dementia
Kapasi, A., & Schneider, J. A. (2020) · Oxford University Press eBooks · doi:10.1093/oso/9780190634230.003.0015 · Cited by 2
Cortical microinfarcts and the aging brain
Kövari, E., & Gold, G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818000-6.00014-7 · Cited by 2
Effect of coenzyme Q10 and/or epigallocatechin gallate on memantine-treated amnesia model in rats
Haleem, E. N. A. A., Ghafour, H. A. A. E., & Awdan, S. A. E. (2021) · Egyptian Pharmaceutical Journal · doi:10.4103/epj.epj_4_21
Young, R. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc242.pub2
(2016) · Elsevier eBooks · doi:10.1016/b978-0-12-804538-1.00036-5
Ollari, J., Deschle, F., Rubiño, V., Blanco, R., Ciufia, N., & Delembert, W. (2023) · Vertex Revista Argentina de Psiquiatría · doi:10.53680/vertex.v34i161.487
Application of consensus criteria
Castellani, R. J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-99651-8.00014-4
Shao, Y., Zhao, X., Xie, Z., Xie, Y., & Guo, S. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1599501
Cognitive Disorders of the Very Old: From Clinic to Pathology
Valcour, V., & Grinberg, L. T. (2025) · Cambridge University Press eBooks · doi:10.1017/9781108985055.015
Walker, L., Simpson, H., Thomas, A. J., & Attems, J. (2024) · Figshare · doi:10.6084/m9.figshare.26681218
Age and the relation of common neuropathologies to dementia in Brazilian adultsPreprint
Farfel, J. M., Nag, S., Capuano, A. W., Sampaio, M. C. D. M., Poole, V. N., Wilson, R. S., & Bennett, D. A. (2026) · medRxiv · doi:10.64898/2026.02.11.26346038
Mild cognitive impairment: A case study
Хайбуллина, Д. Х., Maksimov, Y. N., BELOUSOVA, M. V., & Эдуардович, Г. Б. (2026) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2026-044
Thalamic nuclei insights into Alzheimer’s diseasePreprint
Vidal, J. P. C., Myall, D. J., Pariente, J., Pitcher, T. L., Roberts, R. P., Cawston, E. E., Heron, C. J. L., Anderson, T., Morgan, C., Melzer, T. R., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.26.728015
The impact of delirium on cognitive outcomes in population-based studies
Davis, D. H. J. (2014) · UCL Discovery (University College London) · doi:10.17863/cam.16254
“Brain tissue samples were available in 246 (11% of the follow-up cohort), with donors showing no significant differences from the rest of the cohorts in terms of dementia prevalence and age (Brayne et al. 2009).”
Background
Metadata
- Authors
- Brayne, C., the Cambridge City over-75s Cohort (CC75C) study neuropathology collaboration, Richardson, K., Matthews, F. E., Fleming, J., Hunter, S., Xuereb, J. H., Paykel, E., Mukaetova-Ladinska, E. B., Huppert, F. A., O'Sullivan, A., & Dening, T.
- Affiliations
- University of Cambridge (GB)
- MRC Biostatistics Unit (GB)
- Institute for Ageing and Health, Newcastle University, Wolfson Research Centre, Campus for Ageing and Vitality, Newcastle upon Tyne, UK
- Fulbourn Hospital (GB)
- ORCID
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2009-10-30
- Volume
- 18
- Issue
- 3
- Pages
- 645-658
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W2145741244
- Cited by
- 191
- References
- 32
- Citations by year
- 2026: 5 · 2025: 11 · 2024: 5 · 2023: 14 · 2022: 8 · 2021: 10 · 2020: 7 · 2019: 13 · 2018: 11 · 2017: 15 · 2016: 18 · 2015: 13 · 2014: 12 · 2013: 11 · 2012: 16
- FWCI
- 7.81
- Type
- journal article
- Language
- en
- Open access
- Licence
- cc-by
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Research Bank (Australian Catholic University) (submittedVersion)
- Repository@Hull (Worktribe) (University of Hull) (submittedVersion, cc-by)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research
- Bupa Foundation
- National Institutes of Health
- NIHR Cambridge Biomedical Research Centre
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- late-onset dementia, Alzheimer's disease
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Brain, Catchment Area, Health, Dementia, Female, United Kingdom, Humans, Male, Population Surveillance, Tissue Donors, Cohort Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.